Literature DB >> 26704220

Cognitive Profiles on the Severe Impairment Battery Are Similar in Alzheimer Disease and Down Syndrome With Dementia.

Malcolm B Dick1, Eric Doran, Michael Phelan, Ira T Lott.   

Abstract

Previous research has revealed similarities in the neuropathology, clinical presentation, and risk factors between persons with Alzheimer disease from the general population (GP-AD) and those with Down syndrome (DS-AD). Less is known, however, about the extent of similarities and differences in the cognitive profiles of these 2 populations. Fifty-one moderate to severely demented GP-AD and 59 DS-AD individuals participated in this study which compared the cognitive profiles of these 2 populations on the Severe Impairment Battery (SIB), controlling for sex as well as level of functional ability using a modified version of the Bristol Activities of Daily Living Scale. Overall, the neuropsychological profiles of the higher-functioning individuals within the DS-AD and advanced GP-AD groups, as represented by mean difference scores on the SIB as a whole and across the 9 separate cognitive domains, were very similar to one another after adjusting for sex and functional impairment. To our knowledge, this is the first study to directly compare the cognitive profiles of these 2 populations on the SIB. Findings suggest that the underlying dementia in GP-AD and DS-AD may have corresponding and parallel effects on cognition.

Entities:  

Mesh:

Year:  2016        PMID: 26704220      PMCID: PMC5860802          DOI: 10.1097/WAD.0000000000000132

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  27 in total

1.  Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

Authors:  Bruno Dubois; Howard H Feldman; Claudia Jacova; Harald Hampel; José Luis Molinuevo; Kaj Blennow; Steven T DeKosky; Serge Gauthier; Dennis Selkoe; Randall Bateman; Stefano Cappa; Sebastian Crutch; Sebastiaan Engelborghs; Giovanni B Frisoni; Nick C Fox; Douglas Galasko; Marie-Odile Habert; Gregory A Jicha; Agneta Nordberg; Florence Pasquier; Gil Rabinovici; Philippe Robert; Christopher Rowe; Stephen Salloway; Marie Sarazin; Stéphane Epelbaum; Leonardo C de Souza; Bruno Vellas; Pieter J Visser; Lon Schneider; Yaakov Stern; Philip Scheltens; Jeffrey L Cummings
Journal:  Lancet Neurol       Date:  2014-06       Impact factor: 44.182

2.  Comparison of rating scales for the diagnosis of dementia in adults with Down's syndrome.

Authors:  S Deb; J Braganza
Journal:  J Intellect Disabil Res       Date:  1999-10

3.  Measurement of functional activities in older adults in the community.

Authors:  R I Pfeffer; T T Kurosaki; C H Harrah; J M Chance; S Filos
Journal:  J Gerontol       Date:  1982-05

4.  Evaluation of an 8-item Severe Impairment Battery (SIB-8) vs. the full SIB in moderate to severe Alzheimer's disease patients participating in a donepezil study.

Authors:  F A Schmitt; J Saxton; S H Ferris; J Mackell; Y Sun
Journal:  Int J Clin Pract       Date:  2013-10       Impact factor: 2.503

5.  Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale.

Authors:  R S Bucks; D L Ashworth; G K Wilcock; K Siegfried
Journal:  Age Ageing       Date:  1996-03       Impact factor: 10.668

Review 6.  Cognitive deficits and associated neurological complications in individuals with Down's syndrome.

Authors:  Ira T Lott; Mara Dierssen
Journal:  Lancet Neurol       Date:  2010-06       Impact factor: 44.182

7.  The modified CAMDEX informant interview is a valid and reliable tool for use in the diagnosis of dementia in adults with Down's syndrome.

Authors:  S L Ball; A J Holland; F A Huppert; P Treppner; P Watson; J Hon
Journal:  J Intellect Disabil Res       Date:  2004-09

8.  Diagnosing depression in Alzheimer disease with the national institute of mental health provisional criteria.

Authors:  Edmond Teng; John M Ringman; Leslie K Ross; Ruth A Mulnard; Malcolm B Dick; George Bartzokis; Helen D Davies; Douglas Galasko; Linda Hewett; Dan Mungas; Bruce R Reed; Lon S Schneider; Freddi Segal-Gidan; Kristine Yaffe; Jeffrey L Cummings
Journal:  Am J Geriatr Psychiatry       Date:  2008-06       Impact factor: 4.105

9.  Neuropsychological evaluation of adults with Down's syndrome: patterns of selective impairment in non-demented old adults.

Authors:  J V Haxby
Journal:  J Ment Defic Res       Date:  1989-06

10.  Analyzing the impact of 23 mg/day donepezil on language dysfunction in moderate to severe Alzheimer's disease.

Authors:  Steven H Ferris; Frederick A Schmitt; Judith Saxton; Sharon Richardson; Joan Mackell; Yijun Sun; Yikang Xu
Journal:  Alzheimers Res Ther       Date:  2011-06-20       Impact factor: 6.982

View more
  6 in total

1.  Synaptic actin stabilization protein loss in Down syndrome and Alzheimer disease.

Authors:  Julie C Lauterborn; Conor D Cox; See Wing Chan; Peter W Vanderklish; Gary Lynch; Christine M Gall
Journal:  Brain Pathol       Date:  2019-09-08       Impact factor: 6.508

Review 2.  Dementia in Down syndrome: unique insights for Alzheimer disease research.

Authors:  Ira T Lott; Elizabeth Head
Journal:  Nat Rev Neurol       Date:  2019-03       Impact factor: 42.937

Review 3.  Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome.

Authors:  Panagiotis Zis; Andre Strydom
Journal:  Free Radic Biol Med       Date:  2017-09-01       Impact factor: 7.376

4.  Increased excitatory to inhibitory synaptic ratio in parietal cortex samples from individuals with Alzheimer's disease.

Authors:  Julie C Lauterborn; Pietro Scaduto; Conor D Cox; Anton Schulmann; Gary Lynch; Christine M Gall; C Dirk Keene; Agenor Limon
Journal:  Nat Commun       Date:  2021-05-10       Impact factor: 14.919

Review 5.  TTC3-Mediated Protein Quality Control, A Potential Mechanism for Cognitive Impairment.

Authors:  Xu Zhou; Xiongjin Chen; Tingting Hong; Miaoping Zhang; Yujie Cai; Lili Cui
Journal:  Cell Mol Neurobiol       Date:  2021-02-27       Impact factor: 4.231

6.  Longitudinal assessment of dementia measures in Down syndrome.

Authors:  Lisa Koehl; Jordan Harp; Kathryn L Van Pelt; Elizabeth Head; Frederick A Schmitt
Journal:  Alzheimers Dement (Amst)       Date:  2020-11-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.